首页> 外国专利> compound or a pharmaceutically acceptable salt, solvate, solvate of such a salt or a prodrug thereof, methods for treating or preventing hyperlipidemic conditions, atherosclerosis, alzheimer's disease, and cholesterol-associated tumors, pharmaceutical formulation, process for preparing a compound or a pharmaceutically acceptable salt, solvate, solvate of such a salt or a prodrug thereof, and in combination

compound or a pharmaceutically acceptable salt, solvate, solvate of such a salt or a prodrug thereof, methods for treating or preventing hyperlipidemic conditions, atherosclerosis, alzheimer's disease, and cholesterol-associated tumors, pharmaceutical formulation, process for preparing a compound or a pharmaceutically acceptable salt, solvate, solvate of such a salt or a prodrug thereof, and in combination

机译:化合物或其药学上可接受的盐,溶剂化物,此类盐的溶剂化物或其前药,治疗或预防高脂血症,动脉粥样硬化,阿尔茨海默氏病和胆固醇相关肿瘤的方法,药物制剂,制备化合物或药学上可接受的方法盐,溶剂化物,此类盐的溶剂化物或其前药,及其组合

摘要

"COMPOUND OR A SALT, SOLVATO, SOLVATE OF A SUCH SALT OR PRODUCT OF THIS PHARMACEUTICALLY ACCEPTABLE, METHODS FOR TREATING OR PREVENTING HYPERLIPIDEMIC CONDITIONS, ATHEROSCLEROSIS, MAL OF ALZHEIMER COMPOSTERS, PROMOTEROUS COLUMNS, OR A SALT, SOLVAT, SOLVATE OF SUCH SALT OR PRODUCT OF THIS PHARMACEUTICALLY ACCEPTABLE, AND, COMBINATION ". The compounds of formula (XV): (wherein the variable groups are as defined in) the salts, solvates and solvates of such pharmaceutically acceptable salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
机译:“这种盐或这种药理学可接受的产品的盐或盐的溶剂化物,治疗或预防高脂血症的方法,动脉粥样硬化,多氯联苯制造商的恶意,无色柱或盐,盐,溶剂化物的“药物组合”。描述了式(XV)的化合物:(其中可变基团如在其中所定义),其药学上可接受的盐和前药的盐,溶剂化物和溶剂化物及其在治疗高血脂症中作为胆固醇吸收抑制剂的用途被描述。还描述了它们的制造方法和包含它们的药物组合物。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号